zambia herald : Latest News and In-depth Analysis

Weekly

Coway Announces Financial Results for Q4 and FY2024

Coway\'s 2024 Q4 revenue reached KRW 1,125.7 billion (+12.1% YoY) with an operating profit amounted to KRW 183.4 billion (+10.4% YoY)

Feb 17, 2025 Weekly

Inaugural Longines Hong Kong International Horse Show Unveiled: AsiaWorld-Expo Transforms into a Five-Star Equestrian Paradise, Delivering an Extraordinary Spectacle

HONG KONG,Feb. 14,2025-- For the first time,the prestigious five-star international equestrian event with over 50 years of history in London has chosen Hong Kong as its venue,heralding the fruitful Ye

Feb 17, 2025 Weekly

MicroCloud Hologram Inc. announces optimization of stacked sparse autoencoders through DeepSeek model

SHENZHEN,China,Feb. 14,2025--MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they Announced the deep optimization of stacked sparse

Feb 17, 2025 Weekly

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali

Feb 17, 2025 Weekly

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO

NEW YORK,Feb. 14,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

Feb 17, 2025 Weekly

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

Feb 14, 2025 Weekly
1 ... 63 64 65 66 67 68 69 ... 109